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Abstract 
Every nation in the world has established a National Medication Formulary to account for all the medications present in the country. 
Many countries follow the Essential Medication List provided by the World Health organization (WHO) when making their own 
National Medication Formulary. Our study looked at variations in the National Formularies when compared to the Essential 
Medication Lists. Different relationships such as missing and extra medications lists were formulated and the statistics analyzed. It 
was noted that on average most of the countries studied were lacking 47% of medications, and had 30% additional medications on 
their national formulary. Further studies need to be conducted as Essential Medications may be lacking, or harmful medications may 
be present in a country’s formulary leading to severe health problems. 
 
Medications play a vital role in the treatment of various 
medical conditions.  Therefore, it is important to ensure that 
people receive treatment and remain in good health, thereby 
contributing towards community prosperity. The World 
Health Organization (WHO) is in charge of formulating the 
“Essential Medication List” consisting “of over 350 drugs 
which are updated every two years” 1. Hill et al  (2012) 
conducted a study comparing priority medicines for maternal 
and child health to the national formularies of 89 countries 2 
identifying which medications were lacking in each country’s 
formulary, and the urgent need to amend their formularies so 
that lifesaving medications were readily available. Our study 
aims to look at variations in the National Essential 
Medications Lists in ten developing nations in Africa.  
 
The W.H.O. Expert Committee for the Selection and Use of 
Essential Medicines analyzes and categorizes medication into 
different classes based on their safety and efficacy. During 
the first meeting of the Expert Committee in 1977, the 
essential medications were defined as those medications that 
“are of utmost importance, and are basic, indispensable and 
necessary for the health needs of the population” 3 The 
purpose of the Model List was articulated by the Committee 
at its third meeting held in 1982 in the statement, “they 
should therefore be available at all times in adequate 
amounts and in the appropriate dosage forms.” 4 A 
combination of the definition and its implications has been 
used to describe the essential medicines concept at all 
subsequent meetings of the Committee.” 5 
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The Essential Medication List acts as a template for a country 
when preparing its own national medication formulary. The 
list of medications is very extensive and covers many classes 
including HIV, Cancer, anti-hypertensive, anti-psychotics, anti-
microbial, HRT, antidotes, antibiotics, and NRT. All of these 
medications play major roles in the treatment and prevention 
of serious medical conditions. Countries around the world 
have developed their own national medication formularies to 
meet their individual health concerns. A comparison between 
the WHO Essential Medication List and a country’s national 
medication formulary would allow us to identify the 
differences and analyze the effects these differences may 
have, such as when important medications have been left out 
or harmful ones included in their formularies. We hope that 
this study will help form a database from which a country can 
identify which medications they are missing and which ones 
they have added of their own accord that are not used 
elsewhere. 
 
Method 
The most recent (April 2013) Essential Medication List from 
the WHO was used as a template when comparing to the 
formularies of different countries. Ten developing nations 
from Africa were chosen as a sample group; their formularies 
ranging from 150-250 medications were obtained mostly 
from the WHO National Medicines List/Formulary/Standard 
Treatment Guidelines.6 These countries included Egypt7, 
Eritrea8, Ethiopia9, Kenya10, Lesotho11, Seychelles12, Somalia13, 
Tanzania14, Togo15, and Uganda16. The print copy of the 
Essential Medication list in addition to the countries’ 
formularies were all converted into electronic versions so 
that comparisons could be made electronically, and the data 
stored for future use. Each country’s individual formulary was 
then compared with the template and two separate lists 
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entitled ‘Missing Medications’ and ‘Extra Medications’ 
respectively were then compiled for each country. The 
Missing Medication list contained all the medications that 
were present in the template but absent from the country’s 
formulary list. The Extra medications list contained all the 
medications that were present in the country’s formulary but 
absent from the Essential Medication List. The complete set 
of each country’s Missing and Extra medications list was then 
consolidated and tabulated to allow for comparisons against 
each other, in order to reveal various relationships between 
them. A final list was then made containing the total number 
of countries lacking a specific medication or containing extra 
medications. 
 
Result 
It was found that most countries in the study had an average 
of 237 medications (Table 1) in their formulary as opposed to 
the 350 medications in the Essential Medication List. (Chart 
1) Eritrea had the highest number of medications in the study 
with 354 and Somalia had the lowest with 85 medications.  
 
When comparing the Essential medication list to the 
formularies of the countries (Table 2) it was found that on 
average there were 146 medications (Chart 2) that were 
missing at an average of 41.77% (Chart 3). On average, most 
countries only had 58.23% (Chart 4) of medications that met 
the Essential Medications List standards. Somalia had the 
highest number with 235 missing medications (67%), and 
Eritrea had the lowest number i.e 68 missing medications 
(19%). A total of 57 medications were found to be common to 
both the Essential Medication List, and all the countries’ 
formularies (Table 3). It was also found that 13 medications 
were totally omitted in all the countries (TABLE 4).  
 
It was found that on average 72 medications (Table 5, Chart 
5) or 30.5% (Table 5, Chart 7) of the medications in a 
countries formulary were not found on the Essential 
Medication list. Thus, from the 237 medications in a country’s 
formulary, 165 medications (Table 6, Chart 6) at an average 
of 70% (Table 6, Chart 7) were medications found in the 
Essential Medication List. It is important to remember that 
this value does not reflect the number of missing 
medications; it rather shows us the number of medications 
present in the country’s formulary that are also part of the 
Essential Medication List. When comparing countries to each 
other, it was seen that Egypt was the country with the most 
number of extra medications (113), and Somalia was the 
country with the least number of extra medications (9).  
 
It was also noted that from a total of 404 extra medications, 3 
medications were universally included in all the countries 
formularies even though they are not present in the Essential 
Medication List (Table 6). 
 
Conclusions 
From the study it was seen that on average most of the 
countries were lacking at least 47% of the WHO medications 
(149/311) and had at least 18 medications commonly found 
in their formularies that are not present in The Essential 
Medication List. About 30% of a country’s formulary 
contained extra medications that were not found on the 
Essential Medication List. These could be medications that 
have been previously part of the Essential Medication List but 
have now been removed due to their adverse effects. These 
medications could also be present due to historical uses but 
lack current clinical evidence, thereby putting millions at risk 
of suffering adverse effects.  
 
The results are staggering when extrapolated to the millions 
of people in a given country who would not have access to 
essential medications in the event that they should require 
them, primarily because these medications are not present in 
their country’s formulary.  
 
Discussion 
The study has shown a great deal of disparity between the 
countries’ formularies and the Essential Medication List. This 
study did not take into consideration the GDPs of the 
countries, or the budget allocation for medications. It also did 
not take into consideration the different disease states that 
are particularly prevalent in these countries. These disease 
states may be the primary reason why medications have been 
included, excluded, or added to a given country’s formulary.  
 
It is imperative that further studies are conducted to show 
the differences between other national formularies and The 
WHO Essential Medication List. Further examinations will 
allow us to set up a comprehensive database containing each 
country’s formulary compared to the Essential Medication 
List, which should be a vital asset in providing better 
awareness regarding medications worldwide. Analysis of the 
data will also allow us to look at the medication profile for 
different countries and help understand why a country would 
omit or add a medication, and to address needs efficiently. It 
would also help neighboring countries to form purchasing 
alliances where they would be able to obtain the essential 
medications at better prices. Countries would be able to 
identify the areas in which there is a lack of medication and 
address the issues in a swift manner. Philanthropists and 
NGOs would also be able to target their resources in specific 
and more strategic areas so that the outcomes can be 
achieved in a constant and organized fashion. Most 
importantly, removal of a medication that is harmful or the 
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addition of an essential medication could potentially help 
ensure better health for millions of people. Access to the 
database would also give the general population a chance to 
hold the country accountable for their actions when it comes 
to the provision of medications in their country. Having an 
electronic database linked to every country’s profile would 
help the country identify, keep track of, and understand the 
significance of addition to, and subtraction of, medications 
from future Essential Medication Lists. It is also important to 
note that, not all nations have provided their national 
formularies to the WHO, which would be a requirement for 
future studies to be successful.  
 
References 
1. http://www.who.int/mediacentre/factsheets/fs325/
en/index.html 
2. Hill S, Yang A, Bero L (2012) Priority Medicines for 
Maternal and Child Health: A Global Survey of 
National Essential Medicines Lists. PLoS ONE 7(5): 
e38055. doi:10.1371/journal.pone.0038055 
3. The selection of essential drugs. Report of a WHO 
Expert Committee. Geneva, World Health 
Organization, 1977 (WHO Technical Report Series, 
No. 615). 
4. The use of essential drugs. Report of a WHO Expert 
Committee. Geneva, World Health Organization, 
1983 (WHO Technical Report Series, No. 685). 
5. http://apps.who.int/medicinedocs/en/d/Js4875e/5.
2.html 
6. http://www.who.int/selection_medicines/country_li
sts/en/ 
7. Egypt National Essential Drug List (2006) available at: 
http://www.who.int/selection_medicines/country_li
sts/egy/en/ 
 
8. Eritrea National Essential Drug List (2010) available 
at: 
http://www.who.int/selection_medicines/country_li
sts/eri/en/ 
9. Ethiopia National Essential Drug List (2010) available 
at: 
http://www.who.int/selection_medicines/country_li
sts/eth/en/ 
10. Kenya National Essential Drug List (2010) available 
at: 
http://www.who.int/selection_medicines/country_li
sts/ken/en/ 
11. Lesotho National Essential Drug List (2010) available 
at: 
http://www.who.int/selection_medicines/country_li
sts/lso/en/ 
12. Seychelles National Essential Drug List (2010) 
available at: 
http://www.who.int/selection_medicines/country_li
sts/syc/en/ 
13. Somalia National Essential Drug List (2007) available 
at: 
http://www.who.int/selection_medicines/country_li
sts/som/en/ 
14. Tanzania National Essential Drug List (2007) available 
at: 
http://apps.who.int/medicinedocs/documents/s161
99e/s16199e.pdf 
15. Togo National Essential Drug List (2012) available at: 
http://www.who.int/selection_medicines/country_li
sts/tgo/en/ 
16. Uganda National Essential Drug List (2010) available 
at: 
http://www.who.int/selection_medicines/counry_lis
ts/uga/en/ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
http://z.umn.edu/INNOVATIONS                  2014, Vol. 5, No. 1, Article 147                               INNOVATIONS in pharmacy   3 
 
Commentary POLICY 
 
Table 1. Total and average number of medications in the countries 
 
 
 
 
 
 
Chart 1. Total number of medication in each country (blue), the average number in each country (red)  
and the total number of medications in the Essential Medication List (green) 
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Table 2. Number of medications missing from each country and the average compared to the Essential Medication List. 
 
 
 
 
 
 
Chart 2. Number of medications missing amongst countries compared to the Essential Medication List (Average in Red) 
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Chart 3. Missing medication (%) amongst countries compared to the Essential Medication List (Average in Blue) 
 
 
 
 
 
 
Chart 4. Pie chart showing average distribution (%) of missing medications compared to the Essential Medication List 
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Table 3. List of medications that were present all countries when compared to the Essential Medication List 
 
 
 
 
 
Table 4. List of medications that were omitted from all countries  
even though they are present in the Essential Medication List 
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Table 5.  Table showing the total number of medications, and the number of medications not found in the  
Essential Medication List (extra medications), and the % of medications that are considered extra in each country. 
 
 
 
 
 
 
 
 
 
Table 6.  Table showing the total number of medications, and the number and % of medications                          
found in the Essential Medication List 
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Chart 5. Number of medications not found in the Essential Medication list (Red) 
compared to the number of medications in a country (Blue) 
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Chart 6. Number of medications found in the Essential Medication list (Red)  
compared to the number of medications in a country (Blue) 
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Chart 7. Showing 30% of medication of a country formulary is not part of the Essential medication list. 
 
 
 
 
 
 
 
 
Table 6. List of medications that were present in all countries but not in the Essential Medication List. 
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